Publicaciones en las que colabora con Alberto Gutiérrez Calvo (18)

2022

  1. Higher prevalence of LAP+ (Latency TGFβ-Associated Peptide) T cells at the tissue level in patients with early gastric cancer

    Cellular Immunology, Vol. 382

2021

  1. A reliable and standardizable differential PCR and qPCR methodology assesses HER2 gene amplification in gastric cancer

    Biology, Vol. 10, Núm. 6

  2. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

    The Lancet Oncology, Vol. 22, Núm. 11, pp. 1507-1517

  3. HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients

    Frontiers in Immunology, Vol. 12

  4. TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease

    Journal of Cellular and Molecular Medicine, Vol. 25, Núm. 2, pp. 774-783

2020

  1. Defects at the posttranscriptional level account for the low TCRζ chain expression detected in gastric cancer independently of caspase-3 activity

    Journal of Immunology Research, Vol. 2020

2009

  1. New CD3ζ allele showing a 9-bp deletion in the 3′-UT region of the gene

    Tissue Antigens, Vol. 74, Núm. 4, pp. 356-357

2008

  1. Herpesvirus saimiri transformation may help disclose inherent functional defects of mucosal T lymphocytes in patients with gastric adenocarcinoma

    Immunology and Cell Biology, Vol. 86, Núm. 3, pp. 289-291

2007

  1. FcRγ chain does not replace CD3ζ chain in CD3ζ-deficient T lymphocytes of patients with gastric adenocarcinoma

    Molecular Immunology, Vol. 44, Núm. 9, pp. 2400-2405

2006

  1. Erratum to "Defective CD3ζ chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma" [Cell. Immunol. 238 (2005) 113-122] (DOI:10.1016/j.cellimm.2006.02.007)

    Cellular Immunology

  2. Expression of CD45 and proliferative response to CD3 as suitable classification markers of patients with gastric adenocarcinoma

    Cancer Immunology, Immunotherapy, Vol. 55, Núm. 6, pp. 744-748

2005

  1. Defective CD3ζ chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma

    Cellular Immunology, Vol. 238, Núm. 2, pp. 113-122

2003

  1. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma

    Cancer Immunology, Immunotherapy, Vol. 52, Núm. 11, pp. 708-714

2000

  1. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy

    Anticancer Research, Vol. 20, Núm. 5 C, pp. 3929-3933

1996

  1. A comparative study on the prognostic value of the nuclear expression of protein p53 vis-à-vis histopathology in colorectal cancer

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 13, Núm. 5, pp. 222-226

  2. Acute Small Bowel Obstruction Caused by Endometriosis

    European Journal of Surgery, Vol. 162, Núm. 9, pp. 747-749

1995

  1. Prediction of recurrence in B-C stages of colorectal cancer by p53 nuclear overexpression in comparison with standard pathological features

    European Journal of Surgical Oncology, Vol. 21, Núm. 6, pp. 635-639

  2. Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer

    International Journal of Biological Markers, Vol. 10, Núm. 1, pp. 5-10